Citations

Clear

3030 citation(s) found for "Susan, M".

Heart rate variability is altered by dietary sodium: a randomized cross‐over study in healthy young adults
Allen, Alexander R., Gullixson, Leah R., Wolhart, Sarah C., Kost, Susan L., Eisenach, John H., Schroeder, Darrell R.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.695.17 Get It

Dietary sodium influences intermediate physiological traits in healthy young adults independent of changes in blood pressure. The purpose of this study was to test the hypothesis that dietary sodium affects cardiac autonomic function. In prospective, randomized cross‐over design separated by 1 month or more between diets, 69 normotensive healthy young adults (M/F: 26/43, ages 18–38 yr) consumed a 5‐day low (10 mmol/day), normal (150 mmol), and high sodium (400mmol) diet prior to a protocol examining cardiovascular traits including heart rate variability (HRV) by time domain and frequency domain analysis (Nevrokard). All women were studied in the low hormone phase of the menstrual cycle. Diet did not affect blood pressure, but HR (mean ± SE) was 68±1, 65±1, and 64±1 in low, normal, and high sodium conditions, resp. (RM ANOVA p < 0.01). For HRV there was a main effect of sodium on SDNN, RMSSD, HF, LFnu, HFnu, and LF/HF ratio (p < 0.01 for all). The response to low sodium was most marked and consistent with sympathetic activation, with increased LFnu and LF/HF ratio, and decreased SDNN, RMSSD, and HFnu compared to both normal and high sodium conditions (p ≤ 0.05 for all). These findings suggest that autonomic control of HRV is altered through changes in dietary sodium without changes in blood pressure. Support: UL1 TR000135 , HL‐89331
Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium
Sadler, Brooke , Skidmore, Alex, Gewirtz, Jordan I. , Anderson, Richard C. E. , Ackerman, Laurie L. , Adelson, P. David , Albert, Gregory W. , Aldana, Philipp R. , Alden, Tord D. , Averill, Christine, Baird, Lissa , Bauer, David F. , Bethel-Anderson, Tammy, Bierbrauer, Karin S. , Bonfield, Christopher M. , Brockmeyer, Douglas L. , Chern, Joshua J. , Couture, Daniel E., Durham, Susan, Ellenbogen, Richard G. , Eskandari, Ramin , Fuchs, Herbert E., George, Timothy M., Greene, Stephanie , Gross, Naina L. , Guillaume, Daniel, Hankinson, Todd C. , Heuer, Gregory G. , Iantosca, Mark, Iskandar, Bermans J. , Jackson, Eric M. , Jea, Andrew, Keating, Robert F., Krieger, Mark D., Leonard, Jeffrey R. , Maher, Cormac O. , Mangano, Francesco T. , Mapstone, Timothy B., McComb, J. Gordon , McEvoy, Sean D., Meehan, Thanda, Muhlbauer, Michael S., Oakes, W. Jerry, Olavarria, Greg, O’Neill, Brent R., Ragheb, John , Shannon, Chevis N. , Smith, Jodi L. , Stone, Scellig , Tuite, Gerald F. , Wait, Scott D. , Wellons, John C. , Whitehead, William E. , Park, Tae Sung, Limbrick, David D. , Strahle, Jennifer M. , Skidmore, Alexander, Haller, Gabe , Ahmed, Raheel , Daniels, David J. , Dlouhy, Brian J , Grant, Gerald A. , Graupman, Patrick C. , Greenfield, Jeffrey P. , Guillaume, Daniel J., Johnston, James M. , Khan, Nickalus R. , Menezes, Arnold H. , Selden, Nathan R. W. , Shah, Manish N. , Limbrick, David D.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | June 18, 2021 | Volume: 28 | Issue: 2 | Pages: 167-175

10.3171/2020.12.peds20552 | PMID 34144521 Get It

OBJECTIVE Scoliosis is common in patients with Chiari malformation type I (CM-I)–associated syringomyelia. While it is known that treatment with posterior fossa decompression (PFD) may reduce the progression of scoliosis, it is unknown if decompression with duraplasty is superior to extradural decompression. METHODS A large multicenter retrospective and prospective registry of 1257 pediatric patients with CM-I (tonsils ≥ 5 mm below the foramen magnum) and syrinx (≥ 3 mm in axial width) was reviewed for patients with scoliosis who underwent PFD with or without duraplasty. RESULTS In total, 422 patients who underwent PFD had a clinical diagnosis of scoliosis. Of these patients, 346 underwent duraplasty, 51 received extradural decompression alone, and 25 were excluded because no data were available on the type of PFD. The mean clinical follow-up was 2.6 years. Overall, there was no difference in subsequent occurrence of fusion or proportion of patients with curve progression between those with and those without a duraplasty. However, after controlling for age, sex, preoperative curve magnitude, syrinx length, syrinx width, and holocord syrinx, extradural decompression was associated with curve progression > 10°, but not increased occurrence of fusion. Older age at PFD and larger preoperative curve magnitude were independently associated with subsequent occurrence of fusion. Greater syrinx reduction after PFD of either type was associated with decreased occurrence of fusion. CONCLUSIONS In patients with CM-I, syrinx, and scoliosis undergoing PFD, there was no difference in subsequent occurrence of surgical correction of scoliosis between those receiving a duraplasty and those with an extradural decompression. However, after controlling for preoperative factors including age, syrinx characteristics, and curve magnitude, patients treated with duraplasty were less likely to have curve progression than patients treated with extradural decompression. Further study is needed to evaluate the role of duraplasty in curve stabilization after PFD.
FIRST RESULTS OF A HEAD‐TO‐HEAD TRIAL OF ACALABRUTINIB VERSUS IBRUTINIB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Byrd, John C. , Kater, Arnon P. , Chanan‐Khan, Asher , Furman, Richard R. , Yenerel, Mustafa Nuri , García‐Marco, Jose A., Mato, Anthony R. , Pinilla‐Ibarz, Javier , Seymour, John F. , Leprêtre, Stéphane , Patel, Priti, Higgins, Kara, Sohoni, Sophia, Hillmen, Peter , Ghia, Paolo , O’Brien, Susan , Illés, Árpád , Kay, Neil E. , Stilgenbauer, Stephan , Robak, Tadeusz , Jurczak, Wojciech

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.33_2879 Get It

INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED FOLLICULAR LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY
Lansigan, Frederick , Parameswaran, Vinod, Yacoub, Abdulraheem , Reynolds, Chris, Shao, Spencer H. , Moore, Susan, Coleman, Morton , Andorsky, David , Nowakowski, Grzegorz S. , Rummel, Mathias , Li, J ., Ahn, J. R., Gharibo, Mecide, Sharman, Jeff P. , Lansigan, Frederick

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.23_2881 Get It

Developing competency in communication: Medical student perceptions of patients’ knowledge of anatomy
Dudenkov, Daniel V. , Primus, Jason, Mayer, Susan, Pawlina, Wojciech, Lachman, Nirusha

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.957.20 Get It

Effective communication of medical information by doctors to patients has been found to be positively related to patient satisfaction. In the United States ACGME requires doctors in training to meet the competency of effective communication across many socioeconomic and cultural backgrounds. One of the main contributors to ineffective patient communication is inaccurate perception by the doctor about the extent of a patient's medical knowledge. This study seeks to elucidate medical student perceptions of patients’ knowledge of anatomy based on patient age, sex, occupation, education level and race. It also seeks to understand which of these matter most in guiding students’ assumptions. Patients were asked to complete a questionnaire, created in collaboration with the Mayo Clinic Patient Education Center, which included a multiple choice anatomy quiz and demographic information. First year medical students who had just completed their gross anatomy course were given the same anatomy quiz and a survey that included the demographic profiles of the patients. They were then asked to predict how well the patients scored. Student perceptions of patient knowledge were compared to the actual scores. Pending the results of this study, we anticipate that medical students will over‐estimate patients’ anatomical knowledge. This project was funded by the Department of Anatomy, Mayo Clinic, Rochester, MN.
Aged eNOS−/− mice display increased APP expression, microglial activation, and impaired spatial memory
Austin, Susan A., Santhanam, Anantha V., Hinton, David J., Katušić, Zvonimir S. , Santhanam, Anantha Vijay R., Choi, Doo‐Sup

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1177.3 Get It

Aging and other cardiovascular risk factors are associated with increased incidence of Alzheimer's disease (AD). A common feature of cardiovascular risk factors is decreased endothelial nitric oxide (NO). We studied the effect of a loss of endothelial NO on amyloid precursor protein (APP) related phenotype in aged (14–15 month) endothelial nitric oxide synthase deficient (eNOS −/− ) mice. APP, β‐site APP cleaving enzyme 1, and amyloid beta (Aβ) levels were significantly higher in the brains of aged eNOS −/− mice as compared to aged wild type mice. APP and Aβ 1–40 were increased in hippocampal tissue of eNOS −/− mice as compared to wild type mice. Aged eNOS −/− mice displayed an increased inflammatory phenotype as compared to aged wild type mice. Importantly, aged eNOS −/− mice performed worse in a radial arm maze test of spatial learning and memory as compared to aged wild type mice. These data suggest that chronic loss of endothelial NO may be an important contributor to both Aβ related pathology and cognitive decline. Research was supported by NIH grants HL‐111062 and HL‐91867, the Mayo Alzheimer's Disease Research Center (Z.S.K.), AHA scientist development grant (0835436N, A.V.S.), AHA postdoctoral fellowship 12POST8550003 (S.A.A.), Clinical Pharmacology Training Grant (T32 GM08685) (Trainee S.A.A.), the Samuel Johnson Foundation for Genomics of Addiction Program at Mayo Clinic (D.‐S.C.) and the Mayo Foundation.
Single Topic Conference on Autoimmune Liver Disease from the Canadian Association for the Study of the Liver
Allegretti, Jessica R. , Cheung, Angela , Jones, David , Kerkar, Nanda , Rizvi, Sumera, Bai, Wayne, Gilmour, Susan , Gulamhusein, Aliya , Guttman, Orlee R. , Onófrio, Fernanda de Quadros , Santamaría, Pere , Stueck, Ashley , Swain, Mark G. , Vincent, Catherine , Ricciuto, Amanda , Ricciuto, Amanda , Montaño‐Loza, Aldo J. , Ebadi, Maryam , Levy, Cynthia , Vierling, John Moore , Álvarez, Fernando , Hansen, Bettina E. , MacParland, Sonya A. , Mason, Andrew L. , Hirschfield, Gideon M.

Mayo Clinic

Canadian Liver Journal | June 10, 2021 | Volume: 4 | Issue: 4 | Pages: 401-425

10.3138/canlivj-2021-0006 | PMID 35989897 Get It

Autoimmune liver disease (AILD) spans a spectrum of chronic disorders affecting the liver parenchyma and biliary system. Three main categories of AILD are autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC). This review condenses the presentation and discussions of the Single Topic Conference (STC) on AILD that was held in Ottawa, Ontario, in November 2019. We cover generalities regarding disease presentation and clinical diagnosis; mechanistic themes; treatment paradigms; clinical trials, including approaches and challenges to new therapies; and looking beyond traditional disease boundaries. Although these diseases are considered autoimmune, the etiology and role of environmental triggers are poorly understood. AILDs are progressive and chronic conditions that affect survival and quality of life. Advances have been made in PBC treatment because second-line treatments are now available (obeticholic acid, bezafibrate); however, a significant proportion still present suboptimal response. AIH treatment has remained unchanged for several decades, and data suggest that fewer than 50% of patients achieve a complete response and as many as 80% develop treatment-related side effects. B-cell depletion therapy to treat AIH is in an early stage of development and has shown promising results. An effective treatment for PSC is urgently needed. Liver transplant remains the best option for patients who develop decompensated cirrhosis or hepatocellular carcinoma within specific criteria, but recurrent AILD might occur. Continued efforts are warranted to develop networks for AILD aimed at assessing geo-epidemiological, clinical, and biochemical differences to capture the new treatment era in Canada.
Fear Avoidance Beliefs Are Associated With Perceived Disability in Persons With Vestibular Disorders
Dunlap, Pamela M. , Marchetti, Gregory F., Furman, Joseph M. , Delitto, Anthony , Klatt, Brooke N. , Whitney, Susan L. , Sparto, Patrick J. , Staab, Jeffrey P.

Mayo Clinic

Physical Therapy | June 9, 2021 | Volume: 101 | Issue: 9 | Pages: No page available

10.1093/ptj/pzab147 | PMID 34120180 Get It

Abstract Objective The purpose of this study was to determine the association between fear-avoidance beliefs and disability in 3 months in people with vestibular disorders while accounting for demographic and clinical characteristics. Methods This prospective cohort study included people aged 18 to 100 years who reported dizziness. Participants were recruited from a balance disorders clinic and outpatient physical therapy clinics. All participants completed the Vestibular Activities Avoidance Instrument (VAAI) and the Hospital Anxiety and Depression Scale at baseline and the Vestibular Activities and Participation measure (VAP), dizziness Visual Analogue Scale (VAS), and 12-item Short Form Health Questionnaire at baseline and 3-month follow-up. A modified version of the VAAI included 9 items abstracted from the 81-item VAAI. The relationships between 9-item VAAI scores and follow-up measures of disability were assessed using Spearman correlation coefficients. Linear regression models were analyzed to determine the effect of fear-avoidance beliefs on follow-up VAP score while accounting for baseline outcome measures. Results All participants (n = 404) completed the baseline assessment (mean age = 54 years), and 286 (71%) completed the 3-month assessment. The mean 9-item VAAI score was 25 (SD = 14) at baseline and was significantly associated with VAP (ρ = 0.54), 12-item Short Form Health Questionnaire component scores (ρ = −0.53; −0.44), and dizziness VAS at follow-up (ρ = 0.37). Approximately 38% of the variation in VAP score at follow-up was predicted by age, number of medications, 9-item VAAI score, dizziness VAS, and Hospital Anxiety and Depression Scale-depression score when considered together (R2 = 0.38). Conclusion Fear-avoidance beliefs are associated with measures of disability at 3 months and are predictive of activity limitations and participation restrictions at 3 months when controlling for age, medications, baseline dizziness, and depression symptom severity in people with vestibular disorders. Impact Measurement of fear-avoidance beliefs may provide important prognostic information, suggesting that an assessment of fear-avoidance beliefs could be used by clinicians to identify individuals at greater risk of disability after a vestibular disorder. Lay Summary Fear-avoidance beliefs in people who have vestibular disorders are associated with disability at 3 months and predict limitations in daily activities at 3 months.